3-EpidigitoxigeninCAS# 545-52-8 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 545-52-8 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C23H34O4 | M.Wt | 374.51 |
Type of Compound | Cardenolides and its Sapogenins | Storage | Desiccate at -20°C |
Synonyms | 3α,14-Dihydroxy-5β,14β-card-20(22)-enolide,3α-Digitoxigenin,epi-Digitoxigenin | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
3-Epidigitoxigenin Dilution Calculator
3-Epidigitoxigenin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6702 mL | 13.3508 mL | 26.7016 mL | 53.4031 mL | 66.7539 mL |
5 mM | 0.534 mL | 2.6702 mL | 5.3403 mL | 10.6806 mL | 13.3508 mL |
10 mM | 0.267 mL | 1.3351 mL | 2.6702 mL | 5.3403 mL | 6.6754 mL |
50 mM | 0.0534 mL | 0.267 mL | 0.534 mL | 1.0681 mL | 1.3351 mL |
100 mM | 0.0267 mL | 0.1335 mL | 0.267 mL | 0.534 mL | 0.6675 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Marsdenoside B
Catalog No.:BCX1878
CAS No.:858360-57-3
- 11α-O-Tigloyl-12β-O-acetyltenacigenin B
Catalog No.:BCX1877
CAS No.:154022-51-2
- Ingol-7,8,12-triacetate-3-phenylacetate
Catalog No.:BCX1876
CAS No.:944799-46-6
- Euphorblin R
Catalog No.:BCX1875
CAS No.:2230806-06-9
- Strictinin
Catalog No.:BCX1874
CAS No.:517-46-4
- Tenuiphenone B
Catalog No.:BCX1873
CAS No.:870298-00-3
- Glomeratide A
Catalog No.:BCX1872
CAS No.:1072028-74-0
- Machilin A
Catalog No.:BCX1871
CAS No.:110269-50-6
- Marsdenoside A
Catalog No.:BCX1870
CAS No.:858360-56-2
- Marstenacisside F1
Catalog No.:BCX1869
CAS No.:2902666-68-4
- Epieuphoscopin B
Catalog No.:BCX1868
CAS No.:126372-45-0
- Euphoscopin B
Catalog No.:BCX1867
CAS No.:81557-52-0
- Chrysindin A
Catalog No.:BCX1880
CAS No.:1374852-85-3
- Pebrellin
Catalog No.:BCX1881
CAS No.:13509-93-8
- Hymenoxin
Catalog No.:BCX1882
CAS No.:56003-01-1
- Dehydrodanshenol A
Catalog No.:BCX1883
CAS No.:1444618-61-4
- 2,4,6-Trimethoxyl-3-methylacetophenone
Catalog No.:BCX1884
CAS No.:39701-13-8
- Sibiriquinone A
Catalog No.:BCX1885
CAS No.:723300-08-1
- 3-Epigitoxigenin
Catalog No.:BCX1886
CAS No.:465-10-1
- Lasiokaurinin
Catalog No.:BCX1887
CAS No.:52554-74-2
- Dichlorogelignate
Catalog No.:BCX1888
CAS No.:164030-91-5
- Digoxigenin
Catalog No.:BCX1889
CAS No.:1672-46-4
- 17α-Gitoxigenin
Catalog No.:BCX1890
CAS No.:4433-59-4
- Digitalin, 16-anhydro-
Catalog No.:BCX1891
CAS No.:7044-34-0
Effects of digitoxigenin, digoxigenin, and various cardiac glycosides on cardenolide accumulation in shoot cultures of Digitalis lanata.[Pubmed:17253315]
Planta Med. 1998 Dec;64(8):705-10.
Various cardenolide genins and cardenolide glycosides were administered to light-grown and dark-grown Digitalis lanata shoot cultures to investigate conversion reactions related to the formation and rearrangement of the sugar side chain of Digitalis glycosides. Digitoxigenin was converted to digitoxigen-3-one, 3-Epidigitoxigenin, and digoxigenin. In addition, various cardiac glycosides were formed, including mono-glycosides with glucose, glucomethylose, fucose, and digitalose, as well as the corresponding diglycosides, all containing a terminal glucose. Digitoxosylated cardenolides were not formed, although the light-grown shoot cultures were capable of producing these compounds. Exogenous cardenolide fucosides were not converted into cardenolide digitoxosides. Administration of evatromonoside (digitoxigenin monodigitoxoside) did not force the formation of cardenolide di- or tridigitoxosides. Our results support the hypothesis that cardenolide fucosides and digitoxosides are formed via different biosynthetic routes and that cardenolide genins can be fucosylated but not digitoxosylated, indicating that digitoxosylation may only occur at an earlier stage in the cardenolide pathway.
Synthesis and biological evaluation of 2-hydroxy derivatives of digitoxigenin and 3-epidigitoxigenin.[Pubmed:9839018]
Bioorg Med Chem. 1998 Oct;6(10):1889-94.
The four stereoisomers of the 2-hydroxy derivatives of digitoxigenin and 3-Epidigitoxigenin have been synthesized, their structures established by NMR, and their binding affinity for the digitalis receptor on Na+, K(+)-ATPase evaluated. These derivatives showed lower affinities than the parent compounds. The hydrophilic hydroxy groups in the alpha position are more detrimental to the affinity than hydroxy groups in the beta position.
Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man.[Pubmed:1448185]
Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):226-33.
In vitro experiments were performed with cytosolic and microsomal fractions of human liver specimens in order to investigate which enzyme forms of sulfotransferase (ST) and UDP-glucurosyltransferase (GT) are involved in the metabolism of digitoxin (dt-3) and/or its cleavage products. It was found that the cytosolic STs preferentially react with digitoxigenin (dt-0) whereas microsomal GTs conjugate digitoxigenin-monodigitoxoside (dt-1) and in traces the bisdigitoxoside (dt-2). Dt-3 and dt-0 cannot be glucuronidated. By separation of different sulfotransferases it was found that the hydroxysteroid-ST is responsible for dt-0 and 3-Epidigitoxigenin (epi-dt-0) sulfation. The hydroxysteroid-ST could be purified and characterized (apparent Km and Vmax for dt-0 sulfation: approx. 17 mumol/l and 2.7 nmol/min mg protein, respectively). Of various model substrates and endogenous compounds (steroids, bilirubin) none caused a competitive inhibition of the microsomal dt-1 glucuronidation except dt-2 and dt-3. Therefore it can be supposed that a new GT form catalyses this reaction. It is characterized by an extraordinarily high affinity towards dt-1 with Km values ranging between 0.7 and 27 mumol/l.
Biotransformation of digitoxigenin by ginseng hairy root cultures.[Pubmed:1366480]
Phytochemistry. 1990;29(3):837-43.
Five new compounds (three esters and two glycosides) and seven previously reported compounds were isolated as biotransformation products of digitoxigenin by ginseng hairy root cultures. The new esters and glycosides were elucidated as digitoxigenin stearate, digitoxigenin palmitate, digitoxigenin myristate, 3-Epidigitoxigenin beta-D-gentiobioside and digitoxigenin beta-D-sophoroside using 1H and 13CNMR and FAB mass spectral data. Biotransformations involving esterification (of stearic acid, palmitic acid, myristic acid and lauric acid) and glycosylation (of gentiobiose and sophorose) of digitoxigenin have been demonstrated for the first time in the plant cell and tissue cultures. The hairy roots showed high glycosylation ability to the digitoxigenin molecule.
Stability of mixed function oxidases in frozen rabbit liver.[Pubmed:1153887]
Res Commun Chem Pathol Pharmacol. 1975 Jul;11(3):467-74.
Little information is available on the effect of storage on hepatic mixed function oxidases. Livers from male New Zealand White rabbits were excised, frozen and maintained at -74 degrees C. Assays were conducted immediately on samples of unfrozen liver (day 0) and on thawed samples of the frozen liver at days 49, 92, 142, 181, and 221. Influence of storage on microsomal protein content, aniline hydroxylase activity, cytochrome P-450, and metabolism of digitoxigenin were determined at each time point. After day 92, homogenates gradually began losing the ability to metabolize digitoxigenin to 6beta-hydroxy-3-Epidigitoxigenin, with 50% of the original activity at day 221. The amount of 3-Epidigitoxigenin increased after day 92 in an amount equal to the loss of formation of 6beta-hydroxy-3-Epidigitoxigenin. Microsomal protein content, aniline hydroxylase activity, and cytochrome P-450 content did not significantly change over the course of 221 days.